Article
Finding novel vulnerabilities of hypomorphic BRCA1 alleles
2024-05-28
Abstract excerpt
<h4>ABSTRACT</h4> With the recent rise in CRISPR/Cas9-mediated genome-wide synthetic lethality screens, many new synthetic lethal targets have been identified for diseases with underlying genetic causes such as tumours with BRCA1 mutations. Such screens often use full deficiency of a protein to identify novel vulnerabilities. However, patient-derived mutations not only result in loss of the protein but often als...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6db389fe-8341-53c7-be2a-18acdc7b74d9
- DOI
- 10.1101/2024.05.24.595688
